ExeVir Bio and Nona Biosciences Join Forces in Collaboration Agreement

Jingsong Wang, MD, PhD, Chairman of Nona Biosciences, said, " By combining our respective expertise in antibody engineering and the disease area, we a...

April 06, 2023 | Thursday | News
Luye Pharma, Duopharma partner to expand cholesterol management product access in Malaysia

Developed by Luye Pharma, the product is a traditional Chinese medicine made by using modern technology to ferment special red yeast rice, a natural altern...

April 05, 2023 | Wednesday | News
Health Catalyst Solidifies Multi-Year Partnership with HIE Leader Contexture

Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology centers,...

April 05, 2023 | Wednesday | News
Arrowhead Pharmaceuticals Announces $30 Million Milestone Payment from GSK

GSK4532990 is being developed under the November 2021 exclusive license agreement between Arrowhead and GSK. GSK received an exclusive license to develop a...

April 04, 2023 | Tuesday | News
PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities

The funds will be mainly used to develop lead program Levodopa Cyclops™ for US and EEA marketing, of which early clinical studies already demonstrate...

April 03, 2023 | Monday | News
Labviva raises $20M in Series A to revolutionize life sciences procurement with AI

-Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million ...

March 28, 2023 | Tuesday | News
Merck KGaA Secures Exclusive Worldwide Rights to BAVENCIO® (avelumab)

Merck KGaA, Darmstadt, Germany regains exclusive worldwide rights to develop, manufacture and commercialize BAVENCIO from Pfizer Deal is the latest exam...

March 28, 2023 | Tuesday | News
Premier Health amends circular and announces shareholder meeting results

Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announce...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close